Peanut allergy medicine gets closer to approval

Photo: Michael Jacobs/Art in All of Us/Corbis via Getty Images

A vast majority of experts on a federal allergy panel said a new treatment to minimize reactions to peanut allergies is safe and effective, which may signal possible FDA approval of the drug in January.

Why it matters: The treatment, made by Aimmune Therapeutics and sold under the brand name Palforzia, could provide relief to parents worried about their kids getting an anaphylactic reaction from peanut exposure. 

School nurses are sorely needed, but often absent

Two women stand in two different open doorways that face a hallway.
A medical assistant and a family nurse practitioner who work in Thronton High School's health clinic in Colorado. Photo: RJ Sangosti/The Denver Post via Getty Images

About 25% of schools across the country have no nurse on staff, while 40% have only a part-time nurse, according to National Association of School Nurses data reported by USA Today.

The big picture: If students “don’t have access to a trained medical professional, and something happens, we could be looking at a catastrophe,” a parent leader in Manhattan's Upper West Side told the Wall Street Journal last year in a report that found New York City is undergoing the worst school nurse shortage in 15 years.